// Press Release
The Toker swoops in to share the risks of cannabis smoke on lung health
The Toker swoops in to share the risks of cannabis smoke on lung health A campaign developed by Lung Health Foundation with funding from Health Canada to reach young adults where they are overconsuming online, encouraging them to consider the lung health risk and harm of cannabis smoking TORONTO, Oct. 29, 2020 /CNW/ – The Lung … Continue reading The Toker swoops in to share the risks of cannabis smoke on lung health
SEIU Healthcare Response to Second Reading Vote on the “Time to Care” Act
SEIU Healthcare Response to Second Reading Vote on the “Time to Care” Act Union calls on all members of the Legislative Assembly to unanimously send Bill 13 to third reading for expedited passage into law RICHMOND HILL, ON, Oct. 29, 2020 /CNW/ – SEIU Healthcare, the largest union in the long-term care sector, released the … Continue reading SEIU Healthcare Response to Second Reading Vote on the “Time to Care” Act
How to Design a Specialized Workout to Recover from Injury
How to Design a Specialized Workout to Recover from Injury Getting injured while playing sports or working out is frustrating. Whether it’s something minor like shin splints or something more serious like a torn ACL, injuries can sideline you. Maybe you have been on the bench and want to move again. Jumping full force into … Continue reading How to Design a Specialized Workout to Recover from Injury
Beekeeper Joins UKG Dimensions Technology Partner Network
Beekeeper Joins UKG Dimensions Technology Partner Network UKG (Ultimate Kronos Group) is a Leading Global Provider of HCM, payroll, HR Service Delivery, and Workforce Management SolutionsOAKLAND, Calif., Oct. 27, 2020 — Beekeeper today announced it has joined the UKG Dimensions Technology Partner Network, a fast-growing ecosystem of organizations utilizing the UKG Dimensions solution and intelligent … Continue reading Beekeeper Joins UKG Dimensions Technology Partner Network
KYE Pharmaceuticals Announces Commercial Availability of FIRDAPSE® in Canada
KYE Pharmaceuticals Announces Commercial Availability of FIRDAPSE® in Canada MISSISSAUGA, ON, Oct. 28, 2020 /CNW/ – KYE Pharmaceuticals Inc. (“KYE”), a private company headquartered in Mississauga, Ontario focused on bringing medicines that fulfill clinically significant unmet needs to the Canadian market, today announced an important milestone, FIRDAPSE® (amifampridine phosphate), the first amifampridine product approved in Canada, … Continue reading KYE Pharmaceuticals Announces Commercial Availability of FIRDAPSE® in Canada
Finerenone significantly reduced renal and cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes
Finerenone significantly reduced renal and cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes Finerenone is a first-in-class investigational non-steroidal, selective mineralocorticoid receptor (MR) antagonist that demonstrated renal and cardiovascular benefits in patients with chronic kidney disease and type 2 diabetes Finerenone specifically addresses MR overactivation, a key driver of disease progression … Continue reading Finerenone significantly reduced renal and cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes
Good News eBook FINDING THE LIGHT is Vitamin ‘D’ for the Soul
Good News eBook FINDING THE LIGHT is Vitamin ‘D’ for the Soul FindingTheLight.ca TORONTO, Oct. 28, 2020 /CNW/ – The 200+ page eBook is a time capsule chronicle. It is not a news story or a political piece. It is a one-of-a-kind positive resource comprised of bite-sized essays, breathtaking photographs and poetry, which illuminates the real and relatable thoughts, fears and revelations of 70+ … Continue reading Good News eBook FINDING THE LIGHT is Vitamin ‘D’ for the Soul
CMA-Deloitte report reinforces the urgent need to reduce the backlog of medical services affecting millions of Ontario patients
CMA-Deloitte report reinforces the urgent need to reduce the backlog of medical services affecting millions of Ontario patients TORONTO, Oct. 26, 2020 /CNW/ – With COVID-19 cases rising, the findings in the Deloitte report for the Canadian Medical Association (CMA) on the COVID-19-induced surgical backlog reinforce the serious concerns about patient care that the Ontario … Continue reading CMA-Deloitte report reinforces the urgent need to reduce the backlog of medical services affecting millions of Ontario patients
MAVENCLAD® (cladribine tablets) is available through public drug plans for the majority of eligible Canadians with Relapsing-Remitting Multiple Sclerosis
MAVENCLAD® (cladribine tablets) is available through public drug plans for the majority of eligible Canadians with Relapsing-Remitting Multiple Sclerosis Eligible patients can access PrMAVENCLAD® through public drug plans in seven provinces and two federal programs MISSISSAUGA, ON, Oct. 27, 2020 /CNW/ – EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and … Continue reading MAVENCLAD® (cladribine tablets) is available through public drug plans for the majority of eligible Canadians with Relapsing-Remitting Multiple Sclerosis
Bayshore HealthCare Partners with Amazon to Donate 1,000 Fire Tablets to Seniors in Need
Bayshore HealthCare Partners with Amazon to Donate 1,000 Fire Tablets to Seniors in Need TORONTO, Oct. 27, 2020 /CNW/ – Bayshore HealthCare, one of Canada’s leading home and community care service providers with more than 350,000 clients across the country, has partnered with Amazon to donate 1,000 Fire Tablets to help support isolated seniors, through their Bayshore Foundation for … Continue reading Bayshore HealthCare Partners with Amazon to Donate 1,000 Fire Tablets to Seniors in Need
